@article{william:hal-01796193, TITLE = {{Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial}}, AUTHOR = {William, William N. and Papadimitrakopoulou, Vassiliki and Lee, J. Jack and Mao, Li and Cohen, Ezra E. W. and Lin, Heather Y. and Gillenwater, Ann M. and Martin, Jack W. and Lingen, Mark W. and Boyle, Jay O. and Shin, Dong M. and Vigneswaran, Nadarajah and Shinn, Nancy and Heymach, John V. and Wistuba, Ignacio I. and Tang, Ximing and Kim, Edward S. and Saintigny, Pierre and Blair, Elizabeth A. and Meiller, Timothy and Gutkind, J. Silvio and Myers, Jeffrey and El-Naggar, Adel and Lippman, Scott M.}, URL = {https://univ-lyon1.hal.science/hal-01796193}, JOURNAL = {{JAMA oncology}}, PUBLISHER = {{American Medical Association}}, VOLUME = {2}, NUMBER = {2}, PAGES = {209}, YEAR = {2016}, MONTH = Feb, DOI = {10.1001/jamaoncol.2015.4364}, KEYWORDS = { secondary ; Risk ; Patients ; surgery ; Survival ; Skin ; France ; Growth ; history ; Medical Oncology ; Medicine ; Palliative Care ; pathology ; Time}, HAL_ID = {hal-01796193}, HAL_VERSION = {v1}, }